Skip to content

Case-control study of clinical features of severe anthrax death at 28 days and 90 days

Case-control study of clinical features of severe anthrax death at 28 days and 90 days

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081735
Enrollment
Unknown
Registered
2024-03-11
Start date
2024-03-15
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe anthrax

Interventions

Divide patients into death group and survival group based on their clinical outcomes at 28 and 90 days:None

Sponsors

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age =18 years old, gender unlimited. 2. Meet the following diagnostic criteria for severe anthrax: (1) Smear examination and culture of various secretions, excreta, blood, cerebrospinal fluid, etc., to find typical and capsulated large bacillus, which can be further diagnosed by fluorescent antibody staining, beaded wet sheet examination, specific phage test, animal inoculation, etc. (2) Multiple organ function impairment (MODS) of brain, heart, liver, kidney, blood clotting or more than one organ failure of brain, heart, liver, kidney, blood clotting.

Exclusion criteria

Exclusion criteria: Patients identified by the investigators as having conditions that affect short-term survival and are not eligible for inclusion in the program.

Design outcomes

Primary

MeasureTime frame
28 - and 90-day mortality for severe anthrax;

Secondary

MeasureTime frame
The incidence of respiratory, circulatory, nervous, digestive and coagulation complications in severe anthrax;Peripheral blood biomarkers associated with death at 28 days and 90 days from severe anthrax;Clinical treatment of severe anthrax improves mortality at 28 and 90 days;

Countries

China

Contacts

Public ContactQin Ning

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology

qning@vip.sina.com+86 139 7152 1450

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026